Panagora Asset Management Inc Arch Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$0.23 - $0.33 $6,006 - $8,617	-26,115 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$0.26 - $0.4 $10,407 - $16,012	-40,030 Reduced 60.52%	26,115 $8,000
Q1 2019 May 15, 2019	SELL	$0.35 - $0.5 $9,004 - $12,864	-25,728 Reduced 28.0%	66,145 $26,000
Q4 2018 Feb 14, 2019	BUY	$0.36 - $0.59 $8,708 - $14,272	24,190 Added 35.74%	91,873 $49,000
Q3 2018 Nov 13, 2018	BUY	$0.37 - $0.46 $25,042 - $31,134	67,683 New	67,683 $28,000

Ticker ARTH
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,886,000
Market Cap $247M
Description
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flag...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.